HemoSonics has responded to requests from several clinical sites in Europe and is supporting their investigations to understand the potential utility of the Quantra System for the evaluation of blood coagulation status in COVID-19 patients at the point-of-care. The Quantra Hemostasis Analyzer and its closed system cartridges (QPlus® and QStat® Cartridges) require no blood manipulation after collection which minimizes potential biological exposure to healthcare professionals.